TumorGen is a biotechnology company.
TumorGen has raised $390K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
TumorGen's investors include National Cancer Institute.
TumorGen is headquartered in San Diego, United States.
TumorGen is a biotechnology company.
TumorGen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TumorGen — Funding & Investors." VCBacked, August 26, 2021, https://www.vcbacked.co/company/tumorgen. Accessed November 13, 2026.
VCBacked. (2021). TumorGen — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/tumorgen
{{cite web |title=TumorGen — Funding & Investors |url=https://www.vcbacked.co/company/tumorgen |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at TumorGen? Request a listing update